Ligand validation:6AVI

KNA: nonanoic acid

KNA is a Ligand Of Interest in 6AVI designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6AVI_KNA_A_502	16%	55%	0.213	0.782	0.78	0.96	-	-	7	0	100%	1
6AVI_KNA_B_502	6%	40%	0.279	0.715	0.74	1.58	-	1	5	0	100%	1
6AVI_KNA_B_503	4%	41%	0.367	0.748	0.76	1.52	-	2	5	0	100%	1
5UGM_KNA_B_503	56%	46%	0.169	0.943	0.73	1.35	-	2	2	0	100%	1
6AUG_KNA_A_502	52%	46%	0.164	0.922	0.74	1.34	-	2	11	0	100%	1
4EM9_KNA_A_502	34%	23%	0.184	0.868	2.12	1.09	2	-	0	0	100%	1
6DH9_KNA_A_502	30%	46%	0.176	0.837	0.8	1.26	-	1	0	0	100%	1
8FHF_KNA_B_502	26%	47%	0.18	0.818	0.8	1.25	-	2	10	0	100%	1
7X48_KNA_A_200	77%	20%	0.112	0.953	1.08	2.25	1	2	0	0	100%	0.7455
7WCI_KNA_A_201	76%	37%	0.116	0.953	0.92	1.52	-	2	0	0	100%	0.9

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.